. . . . . . . . . . . . . . . . . . . . "NCT01015833" . "klinisch onderzoek"@nl . . . . . . . . . . "Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer"@en . . . . "Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "356"^^ . . . . . . . . . "2010-02-15T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . "Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer"@en . . . "Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)"@en . . . . . . . . . . "18"^^ . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . . . . . . . . . . . . "clinical trial"@en . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . "2015-05-21T00:00:00Z"^^ . . . .